AdobeStock_324681951.jpeg

NHS Long Term Plan Webinar Series

Smoking Cessation During COVID-19

Increased Risk and Increased Complications  

TBC 2021

13:00 - GMT

Register Now

Proposed Presenters

Sanjay.jpg

Dr Sanjay Agrawal

National specialty adviser for tobacco addiction
NHS England & Improvement

1287734_Jim-McManus-002.jpg

Jim Mcmanus

Director of Public Health

Hertfordshire County Council

TBC 1.jpeg

Industry Partner

To be Confirmed

The COVID-19 epidemic presents a unique public health opportunity for smoking cessation. Smokers are at a higher risk of developing COVID-19 and are also at a higher risk of developing severe COVID-19 complications. Although there are no data available regarding the benefits of smoking cessation during the COVID-19 epidemic, there is evidence to suggest that smoking cessation for 4 weeks or more will lessen the risk of developing COVID-19 as well as the risk of developing severe COVID-19 complications.

Smokers also have an increased risk of developing severe complications once they become infected with SARS-CoV-2. Although there are limited data available, studies from the surgical literature suggest that even 4 weeks of smoking cessation may decrease the risk of adverse outcomes and intubation associated with COVID-19. 

Physicians can play a crucial role in helping smokers quit smoking during the COVID-19 epidemic. Physicians can use telemedicine to advise their patients regarding smoking cessation and to recommend pharmacotherapy.